Differences in the cells that give skin its resilience and strength during wound repair may explain why individuals heal differently, according to a new Yale study published Nov. 23 in the journal Science.
Fibroblasts, the cells that form the protein...
When scientists probe the human genome for clues about disease, they typically focus on the 2% of our genome that make functional proteins. To explore underexamined elements in the genome, a team of Yale investigators developed a tool, called ERVmap, that...
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators at Stanford...
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy drug has meaningful...
Yale researchers have found that a type of air pollution is much more complicated than previous studies indicated.
Using high-powered equipment to analyze air samples, the researchers were able to get a detailed look at the molecular makeup of organic...
A simple modification of a DNA base in small areas of the genome may explain why glioblastoma tumors are so deadly, researchers at Yale and the University of California-San Diego report Nov. 1 in the journal Cell.
Glioblastomas are particularly virulent...
Yale School of Medicine has been awarded a new four-year grant from the Amgen Foundation to provide hands-on laboratory experience to undergraduate students through the Amgen Scholars Program.
Since June 2015, Yale School of Medicine has hosted more than...
Psychedelic drugs such as LSD have a profound impact on human consciousness, particularly perception. Researchers at Yale and the University of Zurich provide new insight into the psychedelic effects of LSD on the brain and potential therapeutic uses of...
An international collaboration led by scientists at Yale has cracked a tough nut in multiple sclerosis: Where are all the genes?
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants....
Yale researchers have developed a way to target RNA with small-molecule drugs, creating a new method for tapping into a vast number of biological mechanisms critical to metabolism and gene expression.
“There is tremendous interest in targeting RNA with...
